[Visualization of tau isoforms by splicing-site specific antibodies]
- PMID: 12235809
[Visualization of tau isoforms by splicing-site specific antibodies]
Abstract
We have developed five tau antibodies that recognize each of 6 human tau isoforms to examine tau lesions such as Alzheimer's neurofibrillary tangles (NFTs) in Alzheimer's disease (AD) as well as other tauopachies. These five antibodies were designed to be specific to splicing-sites of exon 2, exon 3, or exon10 or to the amino acid sequence in exon 3 or exon10. All of newly prepared antibodies as well as anti-human tau stained corresponding recombinant tau isoforms and isolated hyperphosphorylated tau isoforms in an isoform-specific manner on western blot. All antibodies were also found to decorate immunohistochemically NFTs but to be present in unequal amounts in NFTs where two tau isoforms (tau1-352 and tau1-381) were the major species. It is not easy to compare immunoreaction based on immunohistochemical analysis with multiple antibodies. However, the present result strongly suggest unequal occurrence of tau isoforms in Alzheimer's NFTs, indicating other isoform selection in AD than tauopathies.
Similar articles
-
Expression of tau mRNA and soluble tau isoforms in affected and non-affected brain areas in Alzheimer's disease.FEBS Lett. 2004 Oct 8;576(1-2):183-9. doi: 10.1016/j.febslet.2004.09.011. FEBS Lett. 2004. PMID: 15474035
-
Unique Alzheimer's disease paired helical filament specific epitopes involve double phosphorylation at specific sites.Biochemistry. 1997 Jul 1;36(26):8114-24. doi: 10.1021/bi970380+. Biochemistry. 1997. PMID: 9201960
-
Immunohistochemical study of tau accumulation in early stages of Alzheimer-type neurofibrillary lesions.Acta Neuropathol. 2004 Jun;107(6):504-8. doi: 10.1007/s00401-004-0842-2. Epub 2004 Mar 16. Acta Neuropathol. 2004. PMID: 15024583
-
Intrinsically disordered tau protein in Alzheimer's tangles: a coincidence or a rule?Bratisl Lek Listy. 2006;107(9-10):354-8. Bratisl Lek Listy. 2006. PMID: 17262987 Review.
-
Tau oligomers as potential targets for immunotherapy for Alzheimer's disease and tauopathies.Curr Alzheimer Res. 2011 Sep;8(6):659-65. doi: 10.2174/156720511796717177. Curr Alzheimer Res. 2011. PMID: 21605039 Review.